B
102.60
7.10 (7.43%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Bullish | Mixed |
| Diagnostics & Research (Global) | Bullish | Mixed | |
| Stock | BillionToOne, Inc. | - | - |
AIStockmoo Score
0.3
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.25 |
|
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 160.00 (BTIG, 55.95%) | Buy |
| Median | 145.00 (41.33%) | |
| Low | 110.00 (Wells Fargo, 7.21%) | Hold |
| Average | 137.83 (34.34%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 109.93 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 10 Dec 2025 | 160.00 (55.95%) | Buy | 103.70 |
| 01 Dec 2025 | 160.00 (55.95%) | Buy | 113.04 | |
| JP Morgan | 10 Dec 2025 | 145.00 (41.33%) | Buy | 103.70 |
| 01 Dec 2025 | 150.00 (46.20%) | Buy | 113.04 | |
| Jefferies | 01 Dec 2025 | 117.00 (14.04%) | Hold | 113.04 |
| Piper Sandler | 01 Dec 2025 | 150.00 (46.20%) | Buy | 113.04 |
| Stifel | 01 Dec 2025 | 145.00 (41.33%) | Buy | 113.04 |
| Wells Fargo | 01 Dec 2025 | 110.00 (7.21%) | Hold | 113.04 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 23 Dec 2025 | Announcement | BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference |
| 09 Dec 2025 | Announcement | BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair |
| 09 Dec 2025 | Announcement | BillionToOne Reports Third Quarter 2025 Results |
| 02 Dec 2025 | Announcement | BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 |
| 07 Nov 2025 | Announcement | BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares |
| 06 Nov 2025 | Announcement | Gunderson Dettmer Represents Long-Time Client BillionToOne in its Upsized $273.1 Million Initial Public Offering |
| 05 Nov 2025 | Announcement | BillionToOne Announces Pricing of Upsized Initial Public Offering |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |